Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.125    -0.025 (-2.17%)
Bid:
1.05
Ask:
1.20
Spread: 0.15 (14.286%)
Market Cap: £9.62m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Tern PLC: FundamentalVR Series A Funding Round

30 Oct 2019 07:00

Tern PLC (TERN) Tern PLC: FundamentalVR Series A Funding Round 30-Oct-2019 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

30 October 2019

Tern Plc ("Tern" or the "Company")

FundamentalVR Series A Funding Round

Tern Plc (AIM: TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that FVRVS Limited ("FundamentalVR"), a leading virtual reality ("VR") training and data analysis technology platform and one of Tern's existing portfolio companies, has closed a £4.3 million Series A funding round, including a £0.5 million convertible loan note conversion, with a post-money valuation of £11.3 million. This funding round allows for further investment into FundamentalVR's Fundamental Surgery education platform, the first surgical simulation software system to deploy HapticVR(TM), combining VR with cutting-edge haptics (the sense of touch).

The implicit price of the syndicated funding represents a 27% uplift on the investment of £1.9 million made by the Company in FundamentalVR in May and October 2018. Following the funding round, Tern's shareholding in FundamentalVR will be 26.9% with a valuation of £3.0 million, representing a fair value increase of £0.6 million.

The funding round was led by Downing Ventures, with participation from Epic Private Equity and Brighteyes Ventures. Leading medical institutions also participated in the funding round, including Mayo Clinic, one of America's leading centres of medical excellence, and Sana Kliniken, one of Europe's leading medical organisations and the third largest hospital organisation in Germany, which is a strong endorsement of the quality of FundamentalVR's offering.

In conjunction with this funding round, Tern has converted, at a 20% discount to the current fundraising price, £0.5 million of convertible loan notes advanced to FundamentalVR (plus interest). Tern provided these bridging loans to FundamentalVR between April and September 2019.

Based on FundamentalVR's latest statutory accounts for the year ended 31 December 2018, FundamentalVR had net assets of £817,952 at that date and incurred a loss for the year of £2,040,368.

Tern CEO, Al Sisto, said, "We identified early on that FundamentalVR's team was developing a platform that was very special. A training and data analysis offering which could revolutionise the skills development of  surgical practice, while at the same time creating a database of significant importance to the industry. We are delighted that the value and relevance of this exciting business and its entire staff has been recognised by this outstanding syndicate of new investors we helped solidify."

"This is an important milestone for FundamentalVR and it epitomises Tern's strategy to invest in great teams and ideas, not only through the provision of capital, but also with active support and advice for the benefit of our shareholders. Changing the approach to learning and deploying new procedures and products in the world of healthcare is of critical importance for everyone's future and FundamentalVR is leading the way. We look forward to announcing further important developments from the company."

**ENDS**

Enquiries

Tern plc

Al Sisto, CEO

Sarah Payne, Finance Director

 

Via Newgate Communications

 

Allenby Capital Limited

(Nomad and Joint broker)

David Worlidge/Alex Brearley

 

 

Tel: 0203 328 5656

 

Whitman Howard

(Joint broker)

Nick Lovering/Christopher Furness

 

 

Tel: 020 7659 1234

 

Newgate Communications

PR

Elisabeth Cowell/Megan Kovach

 

Tel: 020 3757 6880

 


ISIN:GB00BFPMV798
Category Code:MSCH
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:25848
EQS News ID:899965
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.